A Case of Switching from GnRH Agonist to Antagonist for Castration Resistant Prostate Cancer Control

GnRH antagonist and GnRH agonist are widely used as androgen deprivation therapy for metastatic prostate cancer. A previous report demonstrated that patients with PSA levels of >20 ng/mL using GnRH antagonists showed favorable outcomes in comparison to those using GnRH agonists. An 82-year old ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugimura, Rumiko, Kawahara, Takashi, Miyoshi, Yasuhide, Yao, Masahiro, Chiba, Sawako, Uemura, Hiroji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787414/
https://www.ncbi.nlm.nih.gov/pubmed/31607884
http://dx.doi.org/10.1159/000502859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787414/
https://www.ncbi.nlm.nih.gov/pubmed/31607884
http://dx.doi.org/10.1159/000502859

Ejemplares similares